Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 January Effect Stocks to Buy Right Now

By Josh Enomoto, InvestorPlace Contributor

If you believe in the power of seasonal trends, the concept of The January Effect stocks might pique your interest. Fundamentally, the hypothesis suggests that…

Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential

By Josh Enomoto, InvestorPlace Contributor

If the first rule in the film “Fight Club” is to not talk about fight club, then the same rule applies to penny stocks with…

Silent Winners: 7 Low-Buzz Stocks With High Potential

By Josh Enomoto, InvestorPlace Contributor

In many, if not most cases, you want to avoid betting on the same horse, which makes the concept of hidden-gem stocks quite compelling. Generally,…

Investor Favorites: 7 Dividend Stocks with Strong Buy Ratings

By Josh Enomoto, InvestorPlace Contributor

If you’re looking for the most confidence-inspiring ideas ahead of market ambiguities, don't overlook strong-buy dividend stocks.

NEXI Stock Halted: What’s Going on With NexImmune Shares Today?

By Josh Enomoto, InvestorPlace Contributor

NexImmune faces a likely dissolution of its business. Ahead of a key shareholder meeting, NEXI stock is halted.

Load More